Total News
2
joined at 7 hours ago

    Understanding Glycosylation Inhibitors in Disease Pathways

    As glycobiology continues to expand its impact on biomedical science, the role of enzyme inhibitors—especially those targeting glycan-related pathways—is becomi...

    • ginghamjudd
    .

    CD BioGlyco Launches GalNAc-L96 Platform for Targeted siRNA Delivery to Hep...

    CD BioGlyco has rolled out a newly designed nucleic acid drug delivery system for siRNA- and mRNA-based therapeutics.

    • ginghamjudd
    .